Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study in Patients With Asthma

This study has been completed.
Sponsor:
Information provided by:
Dey
ClinicalTrials.gov Identifier:
NCT00215410
First received: September 13, 2005
Last updated: November 10, 2010
Last verified: February 2008

September 13, 2005
November 10, 2010
Not Provided
October 2003   (final data collection date for primary outcome measure)
Measure of lung function
Same as current
Complete list of historical versions of study NCT00215410 on ClinicalTrials.gov Archive Site
  • Change in lung function, as well as vital signs
  • Physical Exam results, AE reporting, etc
Same as current
Not Provided
Not Provided
 
Study in Patients With Asthma
Not Provided

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

Not Provided
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Asthma
Drug: Formoterol Fumarate
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
36
October 2005
October 2003   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Children with a history of asthma
  • Written guardian approval

Exclusion Criteria:

  • Current or recent asthma exacerbation, requiring hospitalization
  • History of smoking
  • Debilitating or systemic and/or life-threatening diseases.
Both
5 Years to 12 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00215410
DL-055
Not Provided
Director, Clinical Affairs, Dey
Dey
Not Provided
Not Provided
Dey
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP